Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00359554
Status:
TERMINATED
Last Update Posted:
2007-02-07
First Post:
2006-07-31
Brief Title:
Influenza Vaccination of Nursing Home Workers
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Assistance Publique - Hôpitaux de Paris
Study Overview
Official Title:
VAXICOL Effectiveness of Influenza Vaccination of Nursing Home Workers on Mortality of Nursing Home Residents A Cluster Randomized Trial
Status:
TERMINATED
Status Verified Date:
2007-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to demonstrate that influenza vaccination of nursing home workers is an effective intervention for reducing mortality of elderly people
Detailed Description:
Nursing homes will be randomized within each pair in two arms incentive to vaccinate and do-nothing In the arm incentive to vaccinate vaccination campaigns will be carried out with face-to-face interviews of nursing home workers in order to achieve more than 80 of vaccination coverage In the do-nothing nursing home workers will be vaccinated as usual
The main endpoint criterion is all-cause mortality of residents Population sets will be all residents who will be present at start of the influenza season -2 weeks or who will be admitted during the influenza season 2 weeks Onset and end of influenza season will be given by regional influenza surveillance system Secondary criteria are hospitalizations of residents morbidity of nursing home workers A cost-effectiveness ratio of influenza vaccination will be calculated
The main endpoint criterion is all-cause mortality of residents Population sets will be all residents who will be present at start of the influenza season -2 weeks or who will be admitted during the influenza season 2 weeks Onset and end of influenza season will be given by regional influenza surveillance system Secondary criteria are hospitalizations of residents morbidity of nursing home workers A cost-effectiveness ratio of influenza vaccination will be calculated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None